PL2950886T3 - Epitopy białka F syncytialnego wirusa oddechowego - Google Patents

Epitopy białka F syncytialnego wirusa oddechowego

Info

Publication number
PL2950886T3
PL2950886T3 PL14746750T PL14746750T PL2950886T3 PL 2950886 T3 PL2950886 T3 PL 2950886T3 PL 14746750 T PL14746750 T PL 14746750T PL 14746750 T PL14746750 T PL 14746750T PL 2950886 T3 PL2950886 T3 PL 2950886T3
Authority
PL
Poland
Prior art keywords
respiratory syncytial
syncytial virus
protein epitopes
epitopes
protein
Prior art date
Application number
PL14746750T
Other languages
English (en)
Polish (pl)
Inventor
Nancy Ulbrandt
Original Assignee
Medimmune, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune, Llc filed Critical Medimmune, Llc
Publication of PL2950886T3 publication Critical patent/PL2950886T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • C07K16/11Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL14746750T 2013-02-01 2014-01-31 Epitopy białka F syncytialnego wirusa oddechowego PL2950886T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361759664P 2013-02-01 2013-02-01
US201361783380P 2013-03-14 2013-03-14
PCT/US2014/014054 WO2014121021A1 (en) 2013-02-01 2014-01-31 Respiratory syncytial virus f protein epitopes
EP14746750.0A EP2950886B1 (en) 2013-02-01 2014-01-31 Respiratory syncytial virus f protein epitopes

Publications (1)

Publication Number Publication Date
PL2950886T3 true PL2950886T3 (pl) 2020-06-01

Family

ID=51262966

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14746750T PL2950886T3 (pl) 2013-02-01 2014-01-31 Epitopy białka F syncytialnego wirusa oddechowego

Country Status (17)

Country Link
US (1) US10016496B2 (https=)
EP (1) EP2950886B1 (https=)
JP (1) JP6450688B2 (https=)
CN (1) CN105073196B (https=)
AU (1) AU2014212268B2 (https=)
CA (1) CA2900110A1 (https=)
CY (1) CY1122937T1 (https=)
DK (1) DK2950886T3 (https=)
ES (1) ES2778899T3 (https=)
HR (1) HRP20200404T1 (https=)
LT (1) LT2950886T (https=)
PL (1) PL2950886T3 (https=)
PT (1) PT2950886T (https=)
RS (1) RS60056B1 (https=)
SI (1) SI2950886T1 (https=)
SM (1) SMT202000145T1 (https=)
WO (1) WO2014121021A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
EP4353316A3 (en) 2014-01-15 2024-08-21 Medimmune Limited Rsv-specific antibodies and functional parts thereof
JO3555B1 (ar) 2015-10-29 2020-07-05 Merck Sharp & Dohme جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
JP2020503843A (ja) * 2016-10-21 2020-02-06 アディマブ, エルエルシー 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
CN110035771B (zh) 2016-10-21 2024-03-08 阿迪马布有限责任公司 抗呼吸道合胞病毒抗体及其产生和使用方法
WO2018075954A2 (en) * 2016-10-21 2018-04-26 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
TWI683826B (zh) * 2016-11-22 2020-02-01 國立臺灣大學 重組rsv抗原
TWI761453B (zh) 2017-03-01 2022-04-21 英商梅迪繆思有限公司 抗rsv單株抗體配製物
US12024553B2 (en) 2019-04-30 2024-07-02 Medimmune Limited Dosage regimens for and compositions including anti-RSV antibodies
CN111208307B (zh) * 2020-04-21 2020-07-17 上海普铭生物科技有限公司 一种与参照分子具有相同或不同的靶蛋白结合的分子的筛选方法
CN119462859A (zh) * 2023-08-09 2025-02-18 深圳瑞吉生物科技有限公司 呼吸道合胞病毒抗原性多肽、疫苗及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US20020018780A1 (en) 2000-05-25 2002-02-14 Scott Koenig Epitope-based vaccine for respiratory syncytial virus F-protein
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
WO2009128949A2 (en) * 2008-04-18 2009-10-22 Vaxinnate Corporation Compositions of dengue viral proteins and methods of use
EP2408477A4 (en) 2009-03-16 2013-03-27 Sanofi Pasteur Biologics Llc REPLICATION DEFECTS FLAVIVIRUS VACCINE VACCINATORS AGAINST RESPIRATORY SYNZYTIAL VIRUS
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
WO2011043643A1 (en) 2009-10-06 2011-04-14 Medimmune Ltd Rsv-specific binding molecule
WO2011056899A2 (en) 2009-11-03 2011-05-12 Ligocyte Pharmaceuticals, Inc. Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
WO2012089231A1 (en) 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
FI2970398T3 (fi) 2013-03-13 2024-08-06 Us Health Rsv f -prefuusioproteiineja ja niiden käyttö
US9738689B2 (en) 2013-03-13 2017-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use
US9060975B2 (en) 2013-03-14 2015-06-23 Mucosis Bv Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions

Also Published As

Publication number Publication date
JP6450688B2 (ja) 2019-01-09
DK2950886T3 (da) 2020-03-23
JP2016508503A (ja) 2016-03-22
EP2950886A4 (en) 2016-09-07
CA2900110A1 (en) 2014-08-07
WO2014121021A1 (en) 2014-08-07
SI2950886T1 (sl) 2020-06-30
ES2778899T3 (es) 2020-08-12
CN105073196A (zh) 2015-11-18
PT2950886T (pt) 2020-03-26
LT2950886T (lt) 2020-07-10
EP2950886A1 (en) 2015-12-09
HRP20200404T1 (hr) 2020-06-12
US10016496B2 (en) 2018-07-10
CN105073196B (zh) 2020-04-07
EP2950886B1 (en) 2019-12-18
RS60056B1 (sr) 2020-04-30
US20150366960A1 (en) 2015-12-24
SMT202000145T1 (it) 2020-05-08
AU2014212268A1 (en) 2015-08-20
AU2014212268B2 (en) 2018-07-19
CY1122937T1 (el) 2020-10-14

Similar Documents

Publication Publication Date Title
PL2950886T3 (pl) Epitopy białka F syncytialnego wirusa oddechowego
PL3456214T3 (pl) Waporyzator
SG10201801431TA (en) Respiratory syncytial virus (rsv) vaccine
EP3035857A4 (en) ORTHODONTIC CLAMPS
DK3015467T3 (da) Morpholino-oligonukleotidfremstillingsfremgangsmåde
IL243311A0 (en) Novel antibody frameworks
EP2964345A4 (en) LOCKING MECHANISM
DK3076786T3 (da) Fælde
HUE045209T2 (hu) Aramchol-sók
EP2958994A4 (en) Vaccine composition
DK2806934T3 (da) Luftvejsanordning
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
BR112015023852A2 (pt) grelha descartável.
UA29750S (uk) Інгалятор
FR3014969B1 (fr) Fixation temporaire
LT3632373T (lt) Inhaliatorius
EP2980495A4 (en) Humidifier
HUE053417T2 (hu) Inhalátor
PT3035887T (pt) Inalador
HUE050917T2 (hu) Hidrokortizon-tartalmú készítmény
DK2958935T3 (da) Vaccine
DK3008251T3 (da) Offshore forberedelsessystem
FI20135873L (fi) Lukkojärjestely
FI20135458A7 (fi) Lukituselementti
UA24597S (uk) Респіраторна маска